Q32 Bio, Inc. (QTTB)
7.44
-0.33
(-4.25%)
USD |
NASDAQ |
Oct 16, 12:42
Q32 Bio SG&A Expense (TTM) : 17.93M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.93M |
| March 31, 2026 | 17.08M |
| December 31, 2025 | 17.68M |
| September 30, 2025 | 17.12M |
| June 30, 2025 | 17.56M |
| March 31, 2025 | 18.06M |
| December 31, 2024 | 17.96M |
| September 30, 2024 | 21.88M |
| June 30, 2024 | 19.60M |
| March 31, 2024 | 17.56M |
| December 31, 2023 | 14.97M |
| September 30, 2023 | 15.21M |
| June 30, 2023 | 20.83M |
| March 31, 2023 | 26.40M |
| December 31, 2022 | 38.14M |
| September 30, 2022 | 40.77M |
| June 30, 2022 | 41.31M |
| March 31, 2022 | 42.32M |
| Date | Value |
|---|---|
| December 31, 2021 | 36.84M |
| September 30, 2021 | 33.64M |
| June 30, 2021 | 33.71M |
| March 31, 2021 | 33.46M |
| December 31, 2020 | 32.57M |
| September 30, 2020 | 30.77M |
| June 30, 2020 | 28.38M |
| March 31, 2020 | 25.13M |
| December 31, 2019 | 22.21M |
| September 30, 2019 | 21.52M |
| June 30, 2019 | 19.32M |
| March 31, 2019 | 18.31M |
| December 31, 2018 | 17.28M |
| September 30, 2018 | 14.88M |
| June 30, 2018 | 12.76M |
| March 31, 2018 | 8.233M |
| December 31, 2017 | 4.405M |
| September 30, 2017 | 1.718M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 136.25M |
| Beam Therapeutics, Inc. | 125.40M |
| Prime Medicine, Inc. | 54.39M |
| Prelude Therapeutics, Inc. | 20.39M |
| Twist Bioscience Corp. | 290.29M |